Comparison of the number of patients needed to treat with abciximab, eptifibatide and tirofiban to prevent death or myocardial infarction

被引：0
|
作者：
Wilson, MG
Jamal, HH
Wischet, W
Reid, P
机构：
来源：
EUROPEAN HEART JOURNAL | 2000年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P3552
引用
收藏
页码：650 / 650
页数：1
相关论文
共 50 条
  • [1] Comparison by Meta-Analysis of Eptifibatide and Tirofiban to Abciximab in Patients With ST-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
    Ottani, Filippo
    La Vecchia, Luigi
    De Vita, Maria
    Catapano, Ottorino
    Tarantino, Fabio
    Galvani, Marcello
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (02) : 167 - 174
  • [2] Number-needed-to-treat to prevent one death
    Artalejo, FR
    Banegas, JR
    Artalejo, AR
    Guallar-Castillón, P
    LANCET, 1998, 351 (9112) : 1365 - 1365
  • [3] Number-needed-to-treat analysis of the prevention of myocardial infarction and death by antidyslipidemic therapy
    Rembold, CM
    JOURNAL OF FAMILY PRACTICE, 1996, 42 (06) : 577 - 586
  • [4] Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting
    Neumann, FJ
    Hochholzer, W
    Pogatsa-Murray, G
    Schömig, A
    Gawaz, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (05) : 1323 - 1328
  • [5] 'Real world' use of abciximab, tirofiban, and eptifibatide in angioplasty patients.
    Lage, MJ
    Barber, BL
    Scherer, J
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (6A) : 66P - 66P
  • [6] Administration of abciximab to patients receiving tirofiban or eptifibatide: Effect on platelet function
    Lev, EI
    Osende, JI
    Richard, MF
    Robbins, JA
    Delfin, JA
    Rodriguez, O
    Sharma, SK
    Jayasundera, T
    Badimon, JJ
    Marmur, JD
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (03) : 847 - 855
  • [7] Abciximab or eptifibatide: Differences in outcomes of patients treated with abciximab versus eptifibatide as adjunct therapy for primary percutaneous coronary interventions for ST elevation myocardial infarction.
    Hitinder, Gurm
    Share, David
    Smith, Dean E.
    LaLonde, Thomas
    O'Donnell, Michael
    Riba, Arthur
    Changezi, Hameem
    Zughaib, Marcel
    Chandra, Harish
    Safian, Robert
    Moscucci, Mauro
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 292A - 292A
  • [8] Stockpiling oseltamivir - What is the number needed to treat with oseltamivir to prevent one flu death?
    Rouse, A
    BMJ-BRITISH MEDICAL JOURNAL, 2005, 331 (7526): : 1203 - 1203
  • [9] Effectiveness of tirofiban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study)
    Kini, AS
    Richard, M
    Suleman, J
    Perez, N
    Lee, P
    Fisher, EA
    Kamran, M
    Marmur, JD
    Sharma, SK
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (05) : 526 - +
  • [10] Randomized comparison of tirofiban, eptifibatide, and abciximab in minimizing myocardial damage during high-risk percutaneous coronary intervention: TEAM pilot trial
    Sharma, SK
    Kini, A
    Perez, N
    Suleman, J
    Fisher, EA
    Marmur, JD
    Richard, M
    EUROPEAN HEART JOURNAL, 2002, 23 : 642 - 642
12345